Showing results (171-180 of 179) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Plos One|June 1, 2012
Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonistsMarcelo Vizoná Liberato, Alessandro S Nascimento, Steven D Ayers, et al.Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.Medicine|February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled TrialWarren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.Journal of Medicinal Chemistry|June 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through RescaffoldingMatyas Pal Timari, Attila Paczal, Andras Herner, et al.Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.Pharmacological Reviews|August 16, 2023
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023Thomas P Burris, Ian Mitchelle S de Vera, Isabelle Cote, et al.Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.Pageof 18